Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (1317)
|
Core Tip (1318)
|
Full Article (HTML) (4393)
|
Full Article (PDF)-777K (682)
|
Audio-357K (37)
|
Peer-Review Report-122K (213)
|
Answering Reviewers-64K (264)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (12775)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications

World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1573)
|
Core Tip (1591)
|
Full Article (HTML) (14148)
|
Figures (1-4) (1912)
|
Full Article (PDF)-948K (1378)
|
Audio-1310K (34)
|
Peer-Review Report-106K (450)
|
Answering Reviewers-19K (304)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (61)
|
Total Visits (29362)
|
Similar Articles (505)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model

World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (1445)
|
Core Tip (1445)
|
Full Article (HTML) (5331)
|
Figures (1-2) (415)
|
Tables (1-2) (394)
|
Full Article (PDF)-1246K (782)
|
Audio-442K (34)
|
Peer-Review Report-131K (385)
|
Answering Reviewers-120K (240)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (11)
|
Total Visits (19695)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (1334)
|
Core Tip (1334)
|
Full Article (HTML) (4308)
|
Figures (1-3) (419)
|
Tables (1-1) (413)
|
Full Article (PDF)-814K (584)
|
Audio-757K (32)
|
Peer-Review Report-105K (295)
|
Answering Reviewers-109K (263)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (18118)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (1384)
|
Core Tip (1426)
|
Full Article (HTML) (4099)
|
Tables (1-3) (396)
|
Full Article (PDF)-799K (543)
|
Audio-1969K (23)
|
Peer-Review Report-132K (264)
|
Answering Reviewers-50K (234)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (15614)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open